Netherlands Compounding Pharmacies Market Booming Worldwide Report 2021-2028 | GMP Apotheek Mierlo Hout, Apotheek A15, Vemedia

Overview
Compounding pharmaceutical drugs is a cost-effective method of lowering drug costs. However, drug makers in the Netherlands are concerned about the efficacy of compounded drugs that have not been authorized by European regulators.

By the end of 2028, the Netherlands compounding pharmacies market is expected to be worth US$ 520.5 million.

Request Sample Report + Related Graphs & Charts @:
https://www.coherentmarketinsights.com/insight/request-sample/3156

Key Players in This Report Include GMP Apotheek Mierlo Hout, Apotheek A15, Vemedia, and Fagron.

Drivers

Over the forecast period, the Netherlands compounding pharmacies market is expected to expand due to rising demand for lower-cost medications and dermatologic products. Chenodal (chenodeoxycholic acid) oral tablet 250 mg could cost roughly US$ 49,391 for 100 tablets. Cerebrotendinous xanthomatosis (CTX) is a rare hereditary metabolic disease of cholesterol and bile acid metabolism that causes cardiovascular and neurological disorders.

Opportunities

Key market players may concentrate on designing compounding medications for use in companion animals and livestock. However, since federal veterinary medicine policy is mostly based on avoiding medication contaminants in food-producing animals, the use of compounds in pet animals is not strictly regulated.

Restraints

The market's demand is projected to be stifled by strict regulations. The IGJ sent a warning to Academic Medical Centre in April 2018 to stop compounding chenodeoxycholic acid (CDCA) due to a violation of the Dutch Medicines Act.

Key Takeaways

The oral medicine segment of the Netherlands compounding pharmacies market was worth US$ 167.7 million in 2018, and is projected to grow at an annual rate of 8.5 percent to US$ 349.9 million by 2027. Pressure for less expensive medicines and dermatologic products is driving the segment's development.

In terms of sales, the pain relief sector dominated the Dutch compounding pharmacies industry in 2018, contributing about 75.5 percent of the overall revenue, led by hormone replacement therapy. During the forecast period, the segment's rise is due to an increase in the prevalence of acute and chronic pain.

Request for customization in Report @ https://www.coherentmarketinsights.com/insight/request-customization/3156

Market Trends

The Dutch government is working to include a drug loophole in patent law in order to counter exorbitant pharmaceutical costs. In February 2019, the Dutch Patent Act 1995's article 53 (3), second sentence went into effect, establishing a patent exemption for the preparation of medicines in a pharmacy.

In the case with first-time prescriptions, compounded medications are most likely to be bought again because they have personalized advantages not seen in the most widely available drugs. This pattern can be seen in hospital and neighborhood compounding pharmacies alike.

Competitive Landscape

Key companies contributing in the Netherlands compounding pharmacies market are Apotheek A15, Fagron, Apotheek Mierlo Hout, and Vemedia.

Key Developments

The market's major players are concentrating on global growth by mergers and acquisitions. Fagron purchased Humco, a producer, maker, and retailer of proprietary distribution vehicles and branded pharmaceutical goods in the United States, in April 2018.

To broaden their product offerings, key market participants are focusing on forming partnerships. In October 2019, Amsterdam UMC and Quantib, a provider of Medical Imaging AI solutions, formed Quantib-U, a joint venture with University Medical Center Utrecht to build and validate AI applications.

Get Discount On The Purchase Of This Report @: https://www.coherentmarketinsights.com/promo/buynow/3156

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Coherent Market Insights :

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.